RecruitingNot ApplicableNCT06334159

Guided Bone Regeneration Using Fixed vs Non-Fixed Resorbable Collagen Membranes

Guided Bone Regeneration Using Fixed vs Non-Fixed Resorbable Collagen Membranes: A Randomized Controlled Clinical Trial


Sponsor

Universitat Internacional de Catalunya

Enrollment

26 participants

Start Date

Nov 5, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this clinical trial is to compare the horizontal bone gain when grafting a bone substitute with non fixed resorbable collagen membranes (control group), versus fixed resorbable collagen membranes (test group) in resorbed ridges requiring Guided Bone Regeneration (GBR) to facilitate implant placement at 6 months.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Horizontal GBR with the use of non-resorbable pins for the stabilization of the collagen membrane and a procedure called Horizontal GBR without the use of non-resorbable pins for the stabilization of the collagen membrane for people with bone resorption. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHorizontal GBR with the use of non-resorbable pins for the stabilization of the collagen membrane

Horizontal Guided Bone Regeneration, with a mixture of xenograft (Cerabone®) and allograft (Maxgraft®), on a 50-50 mixture ratio, grafted in the area required to be augmented, and then covered by a collagen membrane (Jason® membrane), being fixed with non-resorbable pins (Test Group).

PROCEDUREHorizontal GBR without the use of non-resorbable pins for the stabilization of the collagen membrane

Horizontal Guided Bone Regeneration, with a mixture of xenograft (Cerabone®) and allograft (Maxgraft®), on a 50-50 mixture ratio, grafted in the area required to be augmented, and then covered by a collagen membrane (Jason® membrane), being left unfixed (Control Group).


Locations(1)

Georgios Markantonatos

Barcelona, Sant Cugat Del Vallès, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06334159


Related Trials